mhurhangee/ep-ind-claims huggingface dataset:
A method for encoding data on an optical media comprising: generating un-compensated wobble patterns representing address patterns for track addresses of the optical media; applying a filter to the un-compensated wobble patterns to generate pre-compensated wobble patterns such that when an inverse of the filter is applied to a signal representing the pre-compensated wobble patterns in the presence of noise, the noise is suppressed and the uncompensated wobble patterns are substantially recovered; and embossing the pre-compensated wobble patterns on the optical media; wherein the wobble patterns have a carrier frequency and wherein the inverse of the filter is a band-pass filter centered at the carrier frequency or a low-pass filter having a corner frequency at the carrier frequency. generating un-compensated wobble patterns representing address patterns for track addresses of the optical media; applying a filter to the un-compensated wobble patterns to generate pre-compensated wobble patterns such that when an inverse of the filter is applied to a signal representing the pre-compensated wobble patterns in the presence of noise, the noise is suppressed and the uncompensated wobble patterns are substantially recovered; and embossing the pre-compensated wobble patterns on the optical media; wherein the wobble patterns have a carrier frequency and wherein the inverse of the filter is a band-pass filter centered at the carrier frequency or a low-pass filter having a corner frequency at the carrier frequency.
An optical imaging diagnostic apparatus connected to a probe, said optical imaging diagnostic apparatus further including a transmitting and receiving unit (201, 301) for carrying out transmitting and receiving of light continuously, adapted to obtain reflected light from a biological tissue, the transmitting and receiving unit being axially movable inside a body lumen while rotating, the apparatus being configured to generate a plurality of cross-sectional images of the biological tissue in the axial direction by using line data derived from coherent light produced by interference between the obtained reflected light and reference light, and to display the images thereof, characterized in that the optical imaging diagnostic apparatus further comprises: a calculation unit for respectively calculating signal-intensity change in the circumferential direction of the circumference of the position of the transmitting and receiving unit (201, 301) and signal-intensity change in the radial direction of the body lumen from a plurality of line data used for generation of the cross-sectional image displayed; and a specifying unit for judging, based on the calculated result in the calculation unit, whether or not there exist scatterers consisting of blood cells or floating thrombi, which scatter the light transmitted from the transmitting and receiving unit (201, 301) in an blood flow area inside the body lumen and for specifying the position of the scatterers on the displayed cross-sectional image of the scatterer in case of being judged that there exists the scatterers; and a display unit (215, 317) for displaying a marker indicating that the scatterer exists at the specified position on the displayed cross-sectional image. a calculation unit for respectively calculating signal-intensity change in the circumferential direction of the circumference of the position of the transmitting and receiving unit (201, 301) and signal-intensity change in the radial direction of the body lumen from a plurality of line data used for generation of the cross-sectional image displayed; and a specifying unit for judging, based on the calculated result in the calculation unit, whether or not there exist scatterers consisting of blood cells or floating thrombi, which scatter the light transmitted from the transmitting and receiving unit (201, 301) in an blood flow area inside the body lumen and for specifying the position of the scatterers on the displayed cross-sectional image of the scatterer in case of being judged that there exists the scatterers; and a display unit (215, 317) for displaying a marker indicating that the scatterer exists at the specified position on the displayed cross-sectional image.
A device for using beads to create a cavity in a bone comprising beads, comprising a needle conduit; a connector; a reservoir, wherein said beads are in said reservoir; a driver having a piston, wherein a proximal end of said needle conduit is connected to said driver with said connector, said reservoir is in fluid communication with said driver so that said beads flow into said driver, and said piston is able to be driven by an operator to push said beads flown into said driver into said needle conduit and said piston is able to be pulled away from said needle conduit after said pushing to let said beads flow from said reservoir into said driver; characterized in that said beads are flowable metallic beads able to be attracted by a magnet, and said device further comprises a) means adapted for introducing said beads into a bone by applying a pressure on said beads; and b) a magnet suitable for withdrawing said beads from said bone by magnetic force. a) means adapted for introducing said beads into a bone by applying a pressure on said beads; and b) a magnet suitable for withdrawing said beads from said bone by magnetic force.
A method for producing an enzymatically active sulfatase fusion protein having sulfatase activity, and/or an enzymatically active mammalian sulfatase protein having sulfatase activity, comprising co-expressing in a plant or plant cell: a polynucleotide encoding a mammalian sulfatase fusion protein, and/or a polynucleotide encoding a mammalian sulfatase protein; and a polynucleotide encoding a mammalian sulfatase modifying factor 1 (SUMF1) protein or a SUMF1 fusion protein, wherein the expressed sulfatase fusion protein and/or the expressed mammalian sulfatase protein produced by the method is enzymatically activated in the plant or plant cell by the expressed SUMF1 protein or the expressed SUMF1 fusion protein.
A method of forming a shaped product from an initial blank, comprising: subjecting the initial blank to a hot forming and press hardening operation to form the shaped product with a uniform first tensile strength; and subsequently, partially immersing the shaped product into a fluidized bed that is maintained within a known range of operating temperatures so as to selectively heat a first region of the shaped product to above a known temperature, while simultaneously maintaining below the known temperature a second region of the shaped product that is adjacent to the first region; then cooling the first region such that the first region attains a second tensile strength that is less than the first tensile strength, wherein the first region is immersed into the fluidized bed, while the second region of the shaped product is not immersed into the fluidized bed, and wherein the second region is adjacent to the first region, wherein the known temperature is between 370°C and 800°C; and the method further comprising protecting the second region from being heated to the known temperature, wherein the protecting comprises directing a flow of a cooling fluid toward the second region, wherein a collar is provided about the second region of the shaped product, the collar for protecting the second region of the shaped product from being heated, and wherein the collar one of gas-cools and liquid-cools the second region of the shaped product. subjecting the initial blank to a hot forming and press hardening operation to form the shaped product with a uniform first tensile strength; and subsequently, partially immersing the shaped product into a fluidized bed that is maintained within a known range of operating temperatures so as to selectively heat a first region of the shaped product to above a known temperature, while simultaneously maintaining below the known temperature a second region of the shaped product that is adjacent to the first region; then cooling the first region such that the first region attains a second tensile strength that is less than the first tensile strength, wherein the first region is immersed into the fluidized bed, while the second region of the shaped product is not immersed into the fluidized bed, and wherein the second region is adjacent to the first region, wherein the known temperature is between 370°C and 800°C; and the method further comprising protecting the second region from being heated to the known temperature, wherein the protecting comprises directing a flow of a cooling fluid toward the second region,
An antisense oligonucleotide targeting a human SOD1 pre-mRNA, wherein said antisense oligonucleotide includes SEQ ID NO:1 and/or SEQ ID NO:4, and wherein said oligonucleotide is adapted to induce exon-skipping in said pre-mRNA.
A pharmaceutical composition for use in the simultaneous or sequential administration in the symptomatic and/or prophylactic treatment of respiratory diseases comprising tiotropium bromide with water content less than or equal to 2.5%, formoterol fumarate and budesonide in dry powder form wherein, ∘ the mean particle size of tiotropium bromide with water content less than or equal to 2.5%, formoterol fumarate and budesonide is in the range of 1.5 to 4.5 μm and ∘ said active agents are present in the composition with the ratio of 1: 0,1: 2 to 1: 3: 40 respectively and ∘ lactose which is used as carrier has a mean particle size less than 100 μm. ∘ the mean particle size of tiotropium bromide with water content less than or equal to 2.5%, formoterol fumarate and budesonide is in the range of 1.5 to 4.5 μm and ∘ said active agents are present in the composition with the ratio of 1: 0,1: 2 to 1: 3: 40 respectively and ∘ lactose which is used as carrier has a mean particle size less than 100 μm.
A photoelectric conversion element comprising: a pair of electrodes (11, 15) including a first electrode and a second electrode; a first insulator layer having a first capacitance, and disposed to make contact with the first electrode; a second insulator layer having a second capacitance, which is smaller than the first capacitance of the first insulator layer, and disposed to make contact with the second electrode, wherein the second insulator layer is a solid insulator or an ionic liquid; and an organic semiconductor (13, 13A, 13B) configured to receive a light to generate an electromotive force, and interposed between the first insulator layer and the second insulator layer to make contact therewith, characterized in that the first insulator layer includes an ionic liquid whose major components are a positive ion and a negative ion. a pair of electrodes (11, 15) including a first electrode and a second electrode; a first insulator layer having a first capacitance, and disposed to make contact with the first electrode; a second insulator layer having a second capacitance, which is smaller than the first capacitance of the first insulator layer, and disposed to make contact with the second electrode, wherein the second insulator layer is a solid insulator or an ionic liquid; and an organic semiconductor (13, 13A, 13B) configured to receive a light to generate an electromotive force, and interposed between the first insulator layer and the second insulator layer to make contact therewith, characterized in that the first insulator layer includes an ionic liquid whose major components are a positive ion and a negative ion.
Piezoelectric multilayer component as an intermediate product, having: - a stack of green piezoceramic layers which are arranged one on top of the other and of electrode layers (3a, 3b) of opposite polarity which are arranged alternately one on top of the other, wherein - a first of said electrode layers is applied to a piezoceramic layer and contains a first metal, - a sacrificial layer which cannot function as an electrode layer and which is applied to a further piezoceramic layer and is adjacent to the first electrode layer in the stacking direction, wherein - the sacrificial layer contains a higher concentration of the first metal than does the first electrode layer, characterized by - a second electrode layer, which is applied to a piezoceramic layer, is adjacent to the sacrificial layer in the stacking direction and which contains the same or virtually the same concentration of the first metal as does the sacrificial layer. - a stack of green piezoceramic layers which are arranged one on top of the other and of electrode layers (3a, 3b) of opposite polarity which are arranged alternately one on top of the other, wherein - a first of said electrode layers is applied to a piezoceramic layer and contains a first metal, - a sacrificial layer which cannot function as an electrode layer and which is applied to a further piezoceramic layer and is adjacent to the first electrode layer in the stacking direction, wherein - the sacrificial layer contains a higher concentration of the first metal than does the first electrode layer, characterized by - a second electrode layer, which is applied to a piezoceramic layer, is adjacent to the sacrificial layer in the stacking direction and which contains the same or virtually the same concentration of the first metal as does the sacrificial layer.
A method of wireless communications in a synchronous network for a scheduling entity to communicate with a set of one or more subordinate entities a plurality of subframes via a time division duplex, TDD, carrier, wherein each of the plurality of subframes comprises a header (601; 802), a control portion (606; 812), a data portion (608; 804), and an acknowledgement portion (610; 814), the method comprising: communicating bi-directional data (602, 604; 808, 810) in the header of the subframe, wherein the bi-directional data comprises data packets transmitted by the scheduling entity and data packets received from the one or more subordinate entities; transmitting scheduling information in the control portion of the subframe; transmitting or receiving data information corresponding to the scheduling information in the data portion of the subframe, wherein the data information is associated with the set of subordinate entities and includes all data packets scheduled in the control portion; and receiving or transmitting acknowledgement information corresponding to the data information in the acknowledgement portion of the subframe, wherein all of the data packets in the data portion are acknowledged in the acknowledgement portion. communicating bi-directional data (602, 604; 808, 810) in the header of the subframe, wherein the bi-directional data comprises data packets transmitted by the scheduling entity and data packets received from the one or more subordinate entities; transmitting scheduling information in the control portion of the subframe; transmitting or receiving data information corresponding to the scheduling information in the data portion of the subframe, wherein the data information is associated with the set of subordinate entities and includes all data packets scheduled in the control portion; and receiving or transmitting acknowledgement information corresponding to the data information in the acknowledgement portion of the subframe, wherein all of the data packets in the data portion are acknowledged in the acknowledgement portion.
An adhesive epoxy resin system comprising a. 30-70% by weight of one or more diglycidyl ether bisphenol A resins b. 1-10% by weight of an epoxy novolac resin wherein the epoxy novolac resin is characterized by at least one of the following features: (i) having a viscosity at 25 degrees C of less than 3000 mPa-s according to ASTM D-445, (ii) an average number of epoxide groups per molecule of more than 2 but less than 3.7, and (iii) a molecular weight of less than 750 g/mol c. 10-30% by weight of a polyurethane toughener, provided that if the system is a single component system the polyurethane toughener is blocked with a monofunctional capping agent, d. 5-20% by weight of a flexibilizer e. 1-8% by weight of a hardener, and f. 0.1-% by weight of an aromatic urea based cure accelerator, wherein the weight percents are based on total weight of the system.. a. 30-70% by weight of one or more diglycidyl ether bisphenol A resins b. 1-10% by weight of an epoxy novolac resin wherein the epoxy novolac resin is characterized by at least one of the following features: (i) having a viscosity at 25 degrees C of less than 3000 mPa-s according to ASTM D-445, (ii) an average number of epoxide groups per molecule of more than 2 but less than 3.7, and (iii) a molecular weight of less than 750 g/mol c. 10-30% by weight of a polyurethane toughener, provided that if the system is a single component system the polyurethane toughener is blocked with a monofunctional capping agent, d. 5-20% by weight of a flexibilizer e. 1-8% by weight of a hardener, and f. 0.1-% by weight of an aromatic urea based cure accelerator,
Pressure sensitive adhesive comprising - at least 30 wt% of at least one poly(meth)acrylate; - 10-60 wt% of three-dimensional bodies K made from an inorganic material with a maximum extent of 40 to 300 μm; and - 0.1-10 wt% of at least partly expanded microballoons M, based in each case on the total weight of the pressure sensitive adhesive. - at least 30 wt% of at least one poly(meth)acrylate; - 10-60 wt% of three-dimensional bodies K made from an inorganic material with a maximum extent of 40 to 300 μm; and - 0.1-10 wt% of at least partly expanded microballoons M,
A method for providing services for a traffic flow, comprising: receiving, by a network device, a first packet; if a packet feature of the first packet matches a packet feature of the traffic flow, encapsulating, by the network device, an indication identifier of the traffic flow into the first packet to obtain a second packet, wherein the indication identifier of the traffic flow is used to indicate the service provided for the traffic flow; and sending, by the network device, the second packet; wherein the indication identifier comprises an identifier of the service, wherein the identifier of the service comprises a flag or a color, when a node that the traffic flow passes through provides only one service, the indication identifier carries the color to indicate whether the service needs to be provided and when a node that the traffic flow passes through provides a plurality of services, the indication identifier carries a flag to indicate a combination of one or more services. receiving, by a network device, a first packet; if a packet feature of the first packet matches a packet feature of the traffic flow, encapsulating, by the network device, an indication identifier of the traffic flow into the first packet to obtain a second packet, wherein the indication identifier of the traffic flow is used to indicate the service provided for the traffic flow; and sending, by the network device, the second packet; wherein the indication identifier comprises an identifier of the service, wherein the identifier of the service comprises a flag or a color, when a node that the traffic flow passes through provides only one service, the indication identifier carries the color to indicate whether the service needs to be provided and when a node that the traffic flow passes through provides a plurality of services, the indication identifier carries a flag to indicate a combination of one or more services.
A conductive coating material for spray-coating an electronic component package for shielding said electronic component package, the conductive coating material comprising at least: 100 parts by mass of a binder component containing 5 to 30 parts by mass of a solid epoxy resin that is solid at 25 °C with respect to 100 parts by mass of the binder component, and 20 to 90 parts by mass of a liquid epoxy resin that is liquid at 25 °C with respect to 100 parts by mass of the binder component, a total of the solid epoxy resin and the liquid epoxy resin not exceeding 100 parts by mass; 200 to 1800 parts by mass of metallic particles with respect to 100 parts by mass of the binder component; and 0.3 to 40 parts by mass of a curing agent with respect to 100 parts by mass of the binder component, the conductive coating material having a viscosity of 3 to 30 dPa·s. 100 parts by mass of a binder component containing 5 to 30 parts by mass of a solid epoxy resin that is solid at 25 °C with respect to 100 parts by mass of the binder component, and 20 to 90 parts by mass of a liquid epoxy resin that is liquid at 25 °C with respect to 100 parts by mass of the binder component, a total of the solid epoxy resin and the liquid epoxy resin not exceeding 100 parts by mass; 200 to 1800 parts by mass of metallic particles with respect to 100 parts by mass of the binder component; and 0.3 to 40 parts by mass of a curing agent with respect to 100 parts by mass of the binder component,
Device for irradiating objects, in particular fibers coated with titanium dioxide, comprising a housing and at least one source for emitting electromagnetic radiation, wherein walls which consist of material that is permeable to the electromagnetic radiation and acts as a fiber optic waveguide are provided between the objects that are accommodated in a liquid, such as water, and the source for emission of electromagnetic radiation, wherein sources for the electromagnetic radiation are assigned to the walls, wherein the housing is tubular, and wherein the walls are formed as strips made from a material which is permeable to the electromagnetic radiation that is emitted by the sources, wherein the strips are radially oriented with respect to the housing, wherein the strips face the inside of the housing towards the center thereof.
A method of determining the presence of non-small cell lung cancer in a subject comprising determining the content in the serum of the subject of the microRNA miR-7, miR-199a-3p, miR-20a, miR-23b, miR-24, miR-25, miR-27a, miR-29a, miR-30d, miR-99a, miR-125b, miR-144, miR-145, miR-146a, miR-152, miR-182, miR-199a-5p, miR-221, miR-222, miR-223, miR-320, miR-375, miR-382, miR-423-5p, miR-432 and miR-584, and comparing the content so detected with a known standard amount which correlates to a normal subject, wherein the microRNAs miR-7, miR-20a, miR-23b, miR-24, miR-25, miR-27a, miR-29a, miR-30d, miR-99a, miR-125b, miR-144, miR-145, miR-146a, miR-152, miR-182, miR-199a-5p, miR-199a-3p, miR-221, miR-222, miR-223, miR-320, miR-375, miR-382, miR-423-5p, miR-432 and miR-584 are up-regulated in the serum samples of non-small cell lung cancer patients.